A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19

NCT05815498 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

13553

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: mRNA-1283.222
BIOLOGICAL: mRNA-1273.222
BIOLOGICAL: mRNA-1283.815
BIOLOGICAL: mRNA-1273.815

Sponsor

ModernaTX, Inc.